Acerus Pharmaceuticals Competitors and Similar CompaniesClear all

Acerus Pharmaceuticals's competitors and similar companies include Theramex, Besins Healthcare, TherapeuticsMD and BIAL.

	Acerus Pharmaceuticals Acerus Pharmaceuticals (formerly known as Trimel Pharmaceuticals) is a pharmaceutical company focused on the development and commercialization of men's and women's health products.	Theramex Theramex is a pharmaceutical company that develops treatments for women's health.	Besins Healthcare Besins Healthcare is a company that specializes in therapies for gynecology and andrology.	TherapeuticsMD TherapeuticsMD is a pharmaceutical company focused on producing generic prescriptions and over-the-counter products for women.	BIAL BIAL is a pharmaceutical company that discovers, develops, and commercializes medicines.
Founding Date	Founding Date 2008	Founding Date 2018	Founding Date 1885	Founding Date 2008	Founding Date 1924
Type	Type Private	Type Private	Type Private	Type Public	Type Private
Tags	Tags Healthcare biotech distribution drug development pharma women's health	Tags Healthcare biotech drug development pharma women's health	Tags Healthcare biotech drug development pharma women's health	Tags Healthcare biotech drug development pharma women's health	Tags Healthcare biotech drug development pharma women's health
Locations	Locations Mississauga, CA HQ Mississauga, CA	Locations London, GB HQ Sydney, AU Vilvoorde, BE Paris, FR Berlin, DE Milan, IT Warsaw, PL see more	Locations Monaco, MC HQ Chatswood, AU Bruxelles, BE Sao Paulo, BR see more	Locations Boca Raton, US HQ	Locations Madrid, ES HQ Abidjan, CI Bremen, DE Mörfelden Walldorf, DE Milano, IT Panamá, PA Windsor, GB see more
Employees	Employees 14	Employees 481	Employees 1,1641% increase	Employees 34844% increase	Employees 941
Financial
Revenue (est.)	Revenue (est.) ($4.1m) (FY, 2021)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) $3m (FY, 2025)	Revenue (est.) N/A
Net income	Net income ($33.8m) (FY, 2021)	Net income N/A	Net income N/A	Net income ($569k) (FY, 2025)	Net income N/A
Funding
Total funding raised	Total funding raised $ 18m	Total funding raised N/A	Total funding raised N/A	Total funding raised $ 411.5m	Total funding raised N/A